Wegovy Weight Loss Tablets - 30 Day supply

What are Wegovy® (Semaglutide) tabletss?

Wegovy® is a prescription-only medicine used to support long-term weight management in adults who are living with obesity, or who are overweight and have weight-related health conditions. It is not a cosmetic or short-term solution, but a clinically approved treatment designed to help people manage their weight safely over time.

Wegovy® contains semaglutide, a medicine that mimics a naturally occurring hormone involved in appetite regulation. It is taken as a weekly injection and is only supplied following a medical assessment and approval by a qualified prescriber.

What Wegovy Is and How It Works
Wegovy® works by acting on areas of the brain that regulate appetite and food intake. By slowing how quickly the stomach empties and increasing feelings of fullness after eating, it can help reduce hunger and support lower calorie intake. Many people find that this makes it easier to follow healthier eating habits and maintain long-term changes.

Wegovy® is intended to be used alongside lifestyle changes, including dietary adjustments and increased physical activity. It is not a replacement for these changes, but a medical tool that can support them when weight has been difficult to manage through lifestyle measures alone.

Am I eligible?

Wegovy® is a prescription only medication, not personal preference. It may be suitable for adults with a body mass index (BMI) of 30 or above, or for adults with a BMI of 27 or above who also have a weight-related health condition such as high blood pressure, abnormal cholesterol levels, or type 2 diabetes.

Eligibility is assessed through a medical consultation, which looks at your health history, current medications, previous weight-loss attempts, and overall suitability for treatment. Meeting BMI criteria alone does not guarantee that Wegovy® will be prescribed, as safety and clinical appropriateness must always come first.

https://www.shape8.com/assessment/6?c=3819

How Wegovy® Is Taken?

Wegovy® tablets are taken once a day. It should be taken at least 30 minutes before eating/ drinking/ or taking any other medication and with no more than half a cup of water.
New patients will start on the lowest dose of the treatment and increase after a 30-day period until they’re on the maximum dose. This is done to gradually allow your body to get used to the medication and reduce the chance of suffering from side effects. 

 

Expected Weight Loss and What to Realistically Expect?

Patients achieved >16.6% weight loss on average with lifestyle changes.
Clinical studies have shown that Wegovy can lead to significant average weight loss when used as prescribed and combined with lifestyle changes. Many people experience steady, gradual weight loss over several months rather than rapid changes.

Results vary between individuals. Some people lose more weight than others, and not everyone responds in the same way. Wegovy® does not guarantee weight loss, and continued use is usually needed to maintain results. Stopping treatment can lead to weight regain, which is why Wegovy® is considered a long-term treatment option rather than a short-term fix. 

 

 https://www.shape8.com/dream-weight-loss

https://www.shape8.com/dream-weight-loss

 

 

Wegovy® Side Effects (Semaglutide). What to Expect

Like all prescription weight-loss treatments, Wegovy® (semaglutide) can cause side effects. Many people experience mild, temporary symptoms as the body adjusts, especially during dose increases. If any side effect feels severe, worrying, or does not improve, you should speak to a qualified clinician.

Common side effects:
Nausea
Diarrhea
Vomiting
Constipation
Stomach (abdomen) pain
Headache
Tiredness (fatigue)
Upset stomach
Dizziness
Feeling bloated
Belching
Low blood sugar in people with type 2 diabetes
Gas
Stomach flu
Heartburn
Runny nose or sore throat
 

Serious side effects, when to seek urgent help:

Stop and seek urgent medical advice if you develop symptoms that may suggest a serious reaction. This includes severe and persistent abdominal pain (which may indicate pancreatitis), signs of gallbladder problems (such as upper abdominal pain, fever, jaundice, or pale stools), or symptoms of a serious allergic reaction (swelling of the face/lips/tongue/throat, breathing or swallowing problems, severe rash or itching, fainting, dizziness, or a very rapid heartbeat). Wegovy may also be linked to kidney problems from dehydration if vomiting or diarrhoea persists, changes in vision in people with type 2 diabetes, increased heart rate, and new or worsening depression or suicidal thoughts.

 

Surgery and anaesthetic reminder:

Because Wegovy® can affect stomach emptying, it may increase the chance of food or liquid entering the lungs during procedures involving anaesthesia or deep sedation. Always tell your surgeon, anaesthetist, or clinic team that you are taking Wegovy® before any procedure.

 

Learn more about Managing Common GLP1 Side Effects

https://www.shape8.com/managing-common-glp-1-side-effects

 

Who should not take Wegovy®?

Wegovy® is not appropriate for everyone. Do not use this medication if any of the following apply to you:

You are under 18 years old
You are pregnant, breastfeeding, or planning a pregnancy
You have an allergy to semaglutide or any ingredient in Wegovy
You have Type 1 diabetes
You suffer from severe digestive conditions, including Crohn’s disease, ulcerative colitis, or gastroparesis
You have advanced kidney or liver disease
You have current gallbladder problems (unless your gallbladder has been removed)
You have diabetic retinopathy (diabetes-related eye complications)You or a close family member have had medullary thyroid cancer (MTC)
You have Multiple Endocrine Neoplasia type 2 (MEN 2)


If any of the above apply, Wegovy® may not be suitable and alternative options should be discussed with a qualified clinician.

 

What to eat when on GLP1 medication?

A key part of your weight loss journey is diet. While weight loss medication will reduce the “food noise”, what you eat and drink is incredibly important. Changing your diet is one of the biggest steps you can take on your weight loss journey.

 

Learn more about a GLP1 Diet Plan

 

https://www.shape8.com/diet-plan

Citations

[1] Based on a 72 week study, in addition to a reduced-calorie diet and increased physical activity in adults with an obesity (BMI >30 kg/m²). Study was based on patients without type 2 diabetes and using Wegovy 7.2mg (semaglutide).

[2] Based on a study of adults who had a heart attack, store of peripheral arterial disease and also had obesity. Study was based on Wegovy 2.4mg (semaglutide) and their stancard care medicines (e.g blood pressure). On average the adults were on the trial for 3.5 years. Adults are receive healthy lifestlye counseling help.

[3] Semaglutide in obesity without diabetes in the select trial. https://www.nature.com/articles/s41591-024-02996-7

[4] Semaglutide, a Once-Weekly Human GLP-1 Analog, Does Not Reduce the Bioavailability of the Combined Oral Contraceptive, Ethinylestradiol/Levonorgestrel - https://pmc.ncbi.nlm.nih.gov/articles/PMC4418331/

[5] Based on a study over 68 weeks on adults with obesity and moderate knee OA. https://www.nejm.org/doi/10.1056/NEJMoa2403664

[6] In the Phase III OASIS 4 trial, once-daily oral semaglutide 25 mg achieved a 16.6% mean weight loss for participants who fully adhered to treatment over 64 weeks, compared to 2.7% for the placebo group. https://www.nejm.org/doi/10.1056/NEJMoa2500969

 

Important Safety Information

Wegovy® is not suitable for everyone, and safety is a key part of the prescribing process. It should not be used by people who have a personal or family history of certain thyroid cancers, or by those with specific endocrine conditions. Wegovy must not be used during pregnancy or while breastfeeding.

As with all prescription medicines, side effects can occur. The most commonly reported side effects are related to the digestive system and may include nausea, vomiting, diarrhoea, constipation, or abdominal discomfort. These effects are most common when starting treatment or increasing the dose and often improve as the body adapts.

 

When to Seek Medical Advice Urgently

Although serious side effects are uncommon, urgent medical advice should be sought if you experience severe or persistent abdominal pain, signs of an allergic reaction such as swelling or difficulty breathing, or sudden changes in vision. These symptoms require prompt assessment.

 

Medical Oversight and Prescribing Process

Wegovy® is supplied only following a structured medical consultation that is reviewed by a UK-registered prescriber. This process ensures that the treatment is appropriate, safe, and aligned with current medical guidance.

During treatment, progress may be reviewed and adjustments made if needed. In some cases, treatment may be paused or stopped if it is no longer suitable or if side effects outweigh the benefits.

 

Regulation, Trust, and Patient Safety
As a regulated pharmacy service, prescriptions are issued only when clinically appropriate. There are no automatic approvals, and patient safety is prioritised at every stage. Clear eligibility criteria, medical oversight, and ongoing review are central to how Wegovy treatment is provided.

 

A Balanced, Responsible Approach to Weight Management
Wegovy is one option among several for managing weight. It is not suitable for everyone, and it is not a substitute for healthy lifestyle changes. For those who meet the criteria and are prescribed the medication, it can be a valuable tool in supporting sustainable weight management under medical supervision.

 

FAQs
  • How does Wegovy® Work?

    Wegovy® mimics the action of the natural hormone GLP-1, which regulates appetite and food intake. By acting on specific brain receptors, it helps you feel fuller for longer, reduces hunger, and decreases food cravings. This makes it easier to follow a calorie-controlled diet and maintain weight loss.

  • What are the proven benefits of Wegovy®?

    Clinically proven weight loss – on average, participants lost around 15% of body weight in clinical trials over 68 weeks when combined with diet and exercise.
    Sustained results – benefits maintained for up to two years in long-term studies.
    Heart health protection – a 20% reduction in the risk of heart attack, stroke, or cardiovascular death in high-risk adults, as shown in the select trial.
    Improved cardiometabolic health markers, including lower blood pressure, reduced waist circumference, and improved cholesterol profiles.

  • What are the Wegovy® Dosing & Administration Instructions?

    Starting dose: 0.25 mg once weekly for 4 weeks.
    Gradual dose increase every 4 weeks (0.5 mg → 1.0 mg → 1.7 mg) until reaching the maintenance dose of 2.4 mg once weekly.
    Delivered via the Wegovy® FlexTouch® pre-filled pen for self-injection into the abdomen, thigh, or upper arm.
    Pens are stored refrigerated before opening and can be kept below 30°C for up to 6 weeks after first use.

  • Who Should Not Use Wegovy®?

    Wegovy is not suitable for:

    People under 12 years of age
    Pregnant or breastfeeding women
    Anyone allergic to semaglutide or the listed ingredients
    People using other GLP-1 receptor agonist medications

    Possible Side Effects
    Common side effects include nausea, vomiting, diarrhoea, constipation, and stomach pain, especially during dose escalation. These often lessen over time. Serious but rare side effects can include pancreatitis, gallstones, severe allergic reactions, or bowel obstruction. Always discuss potential risks with your prescriber.


    Why Choose Wegovy® from Shape8
    Private prescription service with full eligibility screening
    Fast, discreet UK delivery
    Ongoing medical support to help you achieve and maintain results
    Guidance on healthy eating and activity plans tailored to your needs

  • What are the Possible Side Effects of Wegovy®

    Common side effects include nausea, vomiting, diarrhoea, constipation, and stomach pain, especially during dose escalation. These often lessen over time. Serious but rare side effects can include pancreatitis, gallstones, severe allergic reactions, or bowel obstruction. Always discuss potential risks with your prescriber.

     

  • What are the Expected Results & Timelines of Wegovy®?

    Wegovy® works gradually, helping you achieve sustainable results rather than rapid, short-term loss. In clinical trials, patients lost on average around 15% of their starting body weight over 68 weeks when combined with a healthy diet and regular physical activity. Many people begin noticing changes in appetite and early weight loss within the first month, with steady progress as the weeks go by.

  • Wegovy® or Mounjaro?

  • What happens if I miss a dose of Wegovy®?

    If you miss a dose, skip that day’s dose and get back on track by taking the scheduled dose the next day.

  • How do I use Wegovy®?

    • Wake up and take 1 Wegovy® pill on an empty stomach with a sip of water (up to 4 ounces).
    • Start your morning. Wait 30 minutes before eating, drinking, or taking other oral medications.

     

    Do Not:

    • Crush, cut, chew, or dissolve the pill
    • Take more than 1 pill each day
    • Share your medication with others
    • Take if the pill appears damaged or discolored (it should be white to light yellow)
    • Store in another container. Store pills in the closed Wegovy® bottle until you are ready to take one, not in another container
    • Take Wegovy® pills with any other liquid besides water
  • Does Wegovy® affect oral contraception?

    Wegovy® is not expected to reduce the effectiveness of oral contraceptives.

    There is no requirement in the Summary of Product Characteristics (SmPC) for women of childbearing age to switch to a non-oral contraceptive method while taking Wegovy®.

  • Can Wegovy® reduce Cardiovascular Risk?

    20% relative risk reduction (1.5% ARR) in MACE*
    Wegovy® is the only weight management medication also approved to reduce cardiovascular risk in adults living with overweight or obesity who have established cardiovascular disease, when used alongside a reduced-calorie diet and increased physical activity.

    Cardiovascular benefit beyond weight loss

    A pre-specified analysis of the SELECT trial found that the reduction in major adverse cardiovascular events (MACE) with Wegovy® was observed regardless of the amount of weight lost at week 20 (both under 5% and 5% or more).

    This suggests that the cardiovascular benefits of Wegovy® may extend beyond weight reduction alone.

     

     

    *  Wegovy® N=8803, placebo N=8801; the patients did not have diabetes. p<0.001.

  • How to store Wegovy® Pills?

    • Keep the pills at room temperature, between 20°C and 25°C
    • Store in a dry place. You may not want to keep Wegovy® in the bathroom if it gets too hot and steamy
    • Keep the pills in the original bottle they came in, with the cap tightly closed
    • Wegovy® comes in a child-resistant bottle. Keep out of reach of children
Your Recently Viewed Items

Author information

All of our medication and condition content is created by fully qualified UK pharmacists and doctors.

Dr Kamran Amjed
Written by

Dr Kamran Amjed

Clinical LeadGPhC number: 7550199
Last Updated Date
Published Date09/03/2026